Practice Transformation Curriculum
This multi-module curriculum is designed for all health-care providers and covers various topics.
Courses within curriculum
- PT101 – The First 3 Months a...
This multi-module curriculum is designed for all health-care providers and covers various topics.
Northeast/Caribbean (NECA) AETC on-demand videos, lectures, and self-study modules courses are available for all healthcare providers including pharma...
In response to newly identified, community-based HIV epidemics, the AETC NCRC has pulled together the following AETC Program and U.S. Centers for Dise...
The purpose of this training is to improve providers’ capacity to provide routine testing and HIV treatment and prevention, and to give a foundation-b...
Slide set provides an overview of HIV and STI testing in the primary care setting; reviews current recommendations for STI screening in the general po...
Training slides from a presentation discussing ways pre-exposure prophylaxis (PrEP) may be delivered in the future, how broadly neutralizing antibodie...
This slide presentation provides an overview of one county's PrEP pilot project (now known as the PrEP Initiative) and its 2-year evaluation to determ...
This presentation is designed for oral health providers. It covers the following:
This series provides best practices and updates for HIV, viral hepatitis, mental health and STI treatment in the correctional setting.
Honoring National Native HIV/AIDS Awareness Day, these training slides review how to start a PrEP program in clinical settings that serve the native c...
Initiation and continuation of PrEP has shifted over the years from specialty care to primary care due to higher patient access, improved rapport thro...
Training slides provide a review of recommended laboratory testing for patients on PrEP, barriers to PrEP engagement during the pandemic, advantages/d...
New England AETC's HIV Resource Library is a compilation of curated resources and education packets on HIV, viral hepatitis, and related public health...
Recorded June 15, 2021.
Training materials review the impact of HIV among Black men who have sex with men (BMSM), discuss perceived ideas about Black M...
This publication discusses the advantages and challenges of telePrEP, the use of telemedicine specifically for pre-exposure prophylaxis (PrEP), and pr...
These presentation slides were from an annual event presented by the Pacific AETC's Arizona regional partner, California Prevention Training Center, a...
Three training slide sets from the "HIV in the Era of COVID-19" telemedicine webinar series designed to share best practices on HIV prevention & c...
Comprehensive package of recommendations and practical tools for clinicians to support provision of pre-exposure prophylaxis (PrEP), especially in New...
Developed by the Northeast/Caribbean AETC's Puerto Rico Regional Partner, this 1-page infographic is designed for providers to help increase patient a...
A downloadable/printable pocket guide for screening and prescribing pre-exposure prophylaxis (PrEP). It includes information about PrEP indications, c...
Training slides describe the safety and efficacy of the Dapivirine vaginal ring for sustained delivery of ARV drugs.
Training slides review the latest updates for the use of PrEP for HIV prevention in the U.S.
(Available until 6/30/2023)
These 18-20 question quizzes cover essential aspects of HIV oral health and prevention, diagnosis and treatment to help end...
Pre-Exposure Prophylaxis (PrEP) is recommended as an HIV prevention option for anyone with risks of acquiring HIV infection th...
Training slides review the background and importance of PrEP in the Southeast and identify provider and patient barriers to PrEP, PrEP eligibility, pr...
Training slides provide a review of RCT and real-world data and explain why people choose the 2-1-1 prescribing schedule.
Training slides review the following:
Training slides review changes to the CDC PrEP Guidelines, updated in December 2021.
CEUs are no longer available.
Training slides review new guidelines for PrEP, and the role of HIV RNA and Antigen/Antibody testing in evaluating HIV while on PrEP.
Training slides review challenges (lack of awareness and interest, and risk perception), and opportunities (improve uptake, sustainability, and adhere...
Webinar recording/slides review current options in HIV treatment, review who should be offered PrEP, and discuss HIV care issues for people with HIV i...
This presentation was part of a two day conference on May 21 and May 22, 2022. Expert HIV providers presented on current STI and HIV recommendation an...
(Recorded 9/9/22)
HIV & Aging, Beyond Viral Suppression: HIV+ Seniors & Long-Term Survivors
Dawn Fukuda, ScM
Director, Office of HIV/AIDS
Bureau o...
(Recorded 9/16/22)
This multidisciplinary program for primary care teams provides updates on discussing important emerging areas of HIV medicine as the...
Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment. The AETC Natio...
Quick guide for clinicians in the role of PrEP, PEP, and other HIV prevention approaches. Includes a video overview, prescribing guide, sexual history...
(Recorded 2/15/23)
In this webinar, Dr. Kevin Ard discussed recent developments in the field of PrEP, such as licensure of long-acting injectable medic...
The PrEP Action Kit includes clinical resources to help providers incorporate PrEP into their practices. It includes tips on taking a comprehensive se...
(Recorded 4/12/23)
This presentation explores the current state of STI among different populations looking at the concerns around HIV PrEP and emerging conc...
Updates on implementation of oral and injectable PrEP in clinical settings
Dr. Hyman Scott, MD, MPH
Assistant Clinical Professor, UC...
Training slides provide an overview of PrEP prescribing and dosing updates for transgender people.
Training slides review the demographics of those people at risk for HIV, different medications available for PrEP and suitable patients for each medic...
(Recorded 5/24/23)
Just over 10 years ago, the first agent for HIV pre-exposure prophylaxis (PrEP) was approved in the United States. Since then, the...
Below is a list of the newest pocket guides created by the MidAtlantic AETC. Descriptions for each resource can be found here:
Training slides discuss current PrEP medications and strategies and how to provide appropriate baseline screenings and follow-up.
Training slides review prescribing pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), how to perform an HIV risk assessment and disc...
Training slides learning objectives include:
Training slides learning objectives aim to:
The National HIV Curriculum (NHC) provides free, up-to-date content for clinicians to learn about HIV diagnosis, treatment, and prevention. The 37 les...
The updated HIV Essentials and Quick HIV Clinical Guides compilation comprises seven of our most popular clinical reference guides in primary care, ur...
The Pacific AETC’s HIV Learning Network (HIVLN) is a free, longitudinal tele-health HIV training and consultation program for HIV clinical care teams...
Recorded 9/6/23
Webinar recording discusses how to identify patients at risk for HIV who may benefit from PrEP, and reviews steps for counseling and pr...
(Recorded 8/9/23)
Presenters provide significant findings and key updates from the 24th International AIDS Conference.
Kenneth May...
The purpose of these trainings is to assist providers who want to offer HIV PrEP but are unsure how to start; and for current prescribers who want to...
Training slides review the following topics:
Training slides emphasize the need for expansive pharmacy-delivered PrEP, and review approaches for establishing a virtual community of practice for p...
(Recorded 12/1/23)
Presented by Dr. Kevin Ard, participants will learn about innovative approaches to HIV prevention using a status-neutral...
This patient-education tool provides basic information about pre-exposure prophylaxis (PrEP) including who should consider taking it and why, how it's...
This resource was created to increase PrEP uptake in Black, indigenous and other people of color (BIPOC) communities. For more detailed information, v...
The purpose of this resource is to assist prescribers with PrEP initiation. It reviews treatment goals, indications for PrEP, and what to consider whe...
The following slides demonstrate current trends of HIV. They describe the guidelines regarding the administration of PrEP/PEP, Rapid Start of ART in t...
This training slide presents updated data long acting injectable (LAI) cabotegravir/rilpivirine for treatment. Differentiate monitoring st...
The following slides demonstrate how to utilize current HIV epidemiology to inform screening practices, incorporate HIV screening recommendations into...
Training slides identify risk factors for HIV infection for adolescents and young adults, approaches to assess sexual health and social history, and s...
Training slides identify why more PrEP studies and options are needed and review non-FDA-approved strategies for HIV prevention.
Training slides review the following:
This presentation is geared towards providers on strategies for engaging transgender persons in effective communications to improve sexual health and...
This program is tailored with oral health professionals in mind to provide current information on the spectrum of HIV care.
Topics covered in the self-...
This free curriculum addresses how to assess, initiate, and monitor HIV PrEP.
These training slides review the indications and contraindications on use of different types of pre-exposure prophylaxis (PrEP), potential use for dox...
These training slides provide the differences in engagement of youth in PrEP services compared to that of adults. Engagement strategies to increase Pr...
(Recorded 3/20/24)
This webinar provides a basic overview of HIV as a chronic medical condition, describes prevention and post-exposure rec...
These guidelines provide tools and resources on billing and coding for pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) services.
These training slides provide updates and impact of use of Doxycycline post-exposure prophylaxis (Doxy-PEP) in clinical practice.
These slides describe the general history and current treatment of human immunodeficiency virus (HIV), recommend HIV testing based on Centers for Dise...
These slides review case studies and updates on effectiveness of pre-exposure prophylaxis (PrEP) among different populations and regions.
These slides review the basic testing algorithm for HIV diagnosis in the U.S., including how to approach ambiguous test results in common clinical sce...
These guideline slides compare and contrast various antiretroviral therapy (ART) options when initiating treatment for people with HIV, as well as ind...
In order to prevent new HIV infections, providers need to understand how to discuss HIV prevention options with people that identify as women. This in...
This guideline is a comprehensive compilation of federal recommendations about biomedical, behavioral, and structural interventions that can help redu...
36 evidence-based recommendations are provided for interventions to optimize the HIV care environment; increase HIV testing and linkage to care, treat...
In this webinar, Dr. Ken Mayer and Julian Dormitzer, NP, address telePrEP and the PrEP at home model for LGBTQIA+ patients. The webinar covers the bas...
Training slides provide a summary of HIV prevention updates presented at CROI 2022, including new data on CAB-LA PrEP and other prevention...
Training slides provide an update on the epidemiology of HIV in the U.S., antiretrovirals, PrEP, the HIV “cure” case, COVID-19 prevention & treatm...
There was a pharmacokinetic study presented at the Conference on Retroviruses and Opportunistic Infections in Boston in February. It evaluated concentrations of tenofovir (TFV) and TFV-diphosphate (DP) in genital and rectal tissue. Also in anogenital fluid samples after administration of oral tenofo...
Tenofovir disoproxil fumarate (TDF) may cause decreases in bone mineral density (BMD). In both HIV-infected patients treated with TDF-containing ARV regimens, and in HIV-uninfected persons who use it for PrEP. A substudy of the large iPrEx trial of TDF/FTC PrEP in MSM and transgender women evaluated...
A long-acting formulation of the investigational integrase inhibitor cabotegravir (CAB) is being studied as a single agent for HIV prevention. (CAB also has been studied, in combination with long-acting rilpivirine, as treatment for people with HIV, see Long-Acting Injectable ART: Cabotegravir + Ril...
The AETC Program's new resource combines the most up-to-date, HIV screening, prevention, and care resources in one mobile app, to provide access to essential point-of-care information and expert clinical support with just one touch.
HIV Care Tools is for busy clinicians from novice-to-expert, clinic...
The FDA recently approved the use of an extended-release injectable formulation of the integrase inhibitor cabotegravir (CAB) for preexposure prophylaxis (PrEP) for adults and adolescents at risk for HIV infection. After two initial intramuscular (IM) injections given 1 month apart, it is administer...
In December 2021, the U.S. Centers for Disease Control and Prevention issued thoroughly revised and updated PrEP guidelines. The guidelines include important new information on the use of oral PrEP (TDF/FTC and TAF/FTC) and recommendations on the use of injectable cabotegravir (CAB) as PrEP.
Key upda...
Pharmacists have been identified by the CDC as key professionals in achieving one of the CDC’s goals of Ending the HIV Epidemic in the U.S. by preventing HIV infection. Below are some of the most common questions received at the AETC National Clinician Consultation Center (NCCC) from pharmacists abo...
The Case: The NCCC received a call from a hospital pediatrician about a baby who was born this morning to a woman with HIV. The baby was born via planned repeat Cesarean section at 39 weeks and 5 days. Records reflect that the mom is on HIV medications and has an undetectable viral load, but the cal...
We are pleased to present the updated list of HIV-related peer-reviewed studies published by AETC-affiliated researchers and faculty in 2023.
If you're affiliated with the AETCs and you published an HIV-related peer-reviewed article in 2023 that is not represented here, let us know so we can update t...